Logo

Shimadzu Will Market, Distribute LumiCyte Technology in Japan

Jun 21, 2002

NEW YORK, June 21 - LumiCyte next week will announce that it has brought on Shimadzu to market and distribute its SELDI-based protein-mapping technology in Japan.

 

The deal, which marks LumiCyte's entrée into a market other than the US, comes with a "multi-million dollar equity investment by Shimadzu.

Breaking News
The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.